We have changed the title of the coming meetup to make the topic a bit clear. Our distinguished guests, John and Sergei will be discussing this complex subject in an entertaining way addressing the issues of different ways to raise equity capital and issues in partnering with a private equity firm. They will also compare differences of raising capital in the US and Russia.
Alternatives for Raising Capital for Company Growth
Institutional Investment - When, Why and How
John Pouschine, Managing Director of Pouschine Cook
John L. Pouschine brings 25 years of private equity investment experience, including roles in operations, extensive board of directors experience, and a very successful record making non-control investments, to Pouschine Cook, which he cofounded in 1997.
Prior to co-founding Pouschine Cook, John was a senior vice president and director of Electra Inc. where he focused on leading many private middle market expansion financings, recapitalizations and acquisitions. In his role as investor and director, John guided numerous companies through growth rates well in excess of the industry. These included Act III Cinemas, DeCrane Aircraft Holdings, Family Christian Stores, Oxford Health Plans, Regent Communications and Steinway Musical Properties. Prior to Electra, John was a vice president of Bradford Ventures, Ltd., where in addition to doing buyouts, he played a leading operating role turning around two portfolio companies. Prior to Bradford, John was an investment banker at Prudential Securities and a commercial banker at JP Morgan.
John graduated from Princeton University and from Harvard Business School. He is a Chairman of the Board of Doe & Ingalls Management, Great Lakes Home Health and Hospice and Latex International. John is also a board member of numerous not-for-profit organizations.
Sergei Petukhov, Ph.D, Managing Director of CLS Capital
Sergei is a managing director of CLS Capital, a private investment and project management company, focuses on selective investments in US, Canadian and European biotech and pharmaceutical companies with products at a late-stage clinical development that have a strong economic incentive to co-develop and commercialize their products in Russia.
Prior to CLS Capital, Sergei held an associate position at medical investment group RUSNANO Russian Nanotechnology investment fund with $5B under management. Prior to RUSNANO, Dr. Petukhov was a an advisor at Kaye Shcoler LLP (New York, USA) intellectual property group.
Dr. Petukhov's scientific background is in molecular biology, biochemistry and biotechnology; he worked and studied at The Rockefeller University, USA; The University of Edinburgh, (Institute of Cell and Molecular Biology), Scotland; The University of Cambridge (Department of Biochemistry), England and Moscow Medical Academy (Department of Biotechnology), Russia.
One of our panelists has a pretty interesting family tree that he traces back for several hundreds years and he will share some stories from his family history.
The event is sponsored by Chip Korn, SNR Denton and Gregory Kegeles - snob.ru, Director of business development, US .
Stay tuned for updates.
Event will take place on April 27, 2011 at
SNR Denton office
1221 Avenue of the Americas
New York, NY 10020-1089